相似文献
1
How to explain multidrug resistance in epilepsy?
Epilepsy Curr. 2005 May-Jun;5(3):107-12. doi: 10.1111/j.1535-7511.2005.05311.x.
2
Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
Epilepsia. 2005 Feb;46(2):224-35. doi: 10.1111/j.0013-9580.2005.31904.x.
3
Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.
Epilepsia. 2006 Apr;47(4):681-94. doi: 10.1111/j.1528-1167.2006.00504.x.
4
Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.
J Pharmacol Exp Ther. 2002 Apr;301(1):7-14. doi: 10.1124/jpet.301.1.7.
5
Mechanisms of drug resistance.
Epileptic Disord. 2005 Sep;7 Suppl 1:S3-9.
6
Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
Biomed Res Int. 2015;2015:194541. doi: 10.1155/2015/194541. Epub 2015 Sep 27.
7
ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.
Pharmacol Res. 2019 Jun;144:357-376. doi: 10.1016/j.phrs.2019.04.031. Epub 2019 Apr 30.
8
Mechanisms of drug resistance in epilepsy: relevance for antiepileptic drug discovery.
Expert Opin Drug Discov. 2009 Jan;4(1):23-32. doi: 10.1517/17460440802611729.
9
ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Epilepsia. 2007;48 Suppl 5:140-9. doi: 10.1111/j.1528-1167.2007.01302.x.
10
Computer-Aided Recognition of ABC Transporters Substrates and Its Application to the Development of New Drugs for Refractory Epilepsy.
Mini Rev Med Chem. 2017;17(3):205-215. doi: 10.2174/1389557516666161013103408.
引用本文的文献
1
Genome-wide association meta-analyses of drug-resistant epilepsy.
EBioMedicine. 2025 May;115:105675. doi: 10.1016/j.ebiom.2025.105675. Epub 2025 Apr 15.
2
Cerebrospinal fluid-specific oligoclonal bands in dogs with idiopathic epilepsy.
J Vet Intern Med. 2025 Jan-Feb;39(1):e17265. doi: 10.1111/jvim.17265.
3
Insight into Drug Resistance in Status Epilepticus: Evidence from Animal Models.
Int J Mol Sci. 2023 Jan 20;24(3):2039. doi: 10.3390/ijms24032039.
4
Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An Study.
Front Neurol. 2022 Jul 22;13:888479. doi: 10.3389/fneur.2022.888479. eCollection 2022.
5
Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule.
Int J Mol Sci. 2022 Jul 4;23(13):7426. doi: 10.3390/ijms23137426.
6
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy.
Ann Clin Transl Neurol. 2021 Jul;8(7):1376-1387. doi: 10.1002/acn3.51374. Epub 2021 May 21.
7
Pharmacokinetic, pharmacodynamic, and neurochemical investigations of lamotrigine-pentylenetetrazole kindled mice to ascertain it as a reliable model for clinical drug-resistant epilepsy.
Animal Model Exp Med. 2020 Aug 3;3(3):245-255. doi: 10.1002/ame2.12131. eCollection 2020 Sep.
8
A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy.
Int J Mol Sci. 2019 Jul 30;20(15):3717. doi: 10.3390/ijms20153717.
9
Use and Future Prospects of in Vivo Microdialysis for Epilepsy Studies.
ACS Chem Neurosci. 2019 Apr 17;10(4):1875-1883. doi: 10.1021/acschemneuro.8b00271. Epub 2018 Jul 23.
10
In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2.
Molecules. 2017 Sep 29;22(10):1484. doi: 10.3390/molecules22101484.
本文引用的文献
1
Major targets and mechanisms of antiepileptic drugs and major reasons for failure.
Adv Neurol. 2006;97:417-27.
2
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
NeuroRx. 2005 Jan;2(1):86-98. doi: 10.1602/neurorx.2.1.86.
3
Pharmacogenomics in cancer therapy: is host genome variability important?
Trends Pharmacol Sci. 2004 Sep;25(9):457-64. doi: 10.1016/j.tips.2004.07.007.
4
Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy.
Ann Pharmacother. 2004 Oct;38(10):1631-4. doi: 10.1345/aph.1E068. Epub 2004 Aug 24.
5
Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats.
Neuroreport. 2004 Jul 19;15(10):1657-61. doi: 10.1097/01.wnr.0000134840.10390.a4.
6
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies.
Blood. 2004 Oct 1;104(7):1940-51. doi: 10.1182/blood-2003-07-2490. Epub 2004 Jun 24.
7
The neurobiology of antiepileptic drugs.
Nat Rev Neurosci. 2004 Jul;5(7):553-64. doi: 10.1038/nrn1430.
8
ABC transporters and the blood-brain barrier.
Curr Pharm Des. 2004;10(12):1295-312. doi: 10.2174/1381612043384844.
9
The role of ABC transporters in clinical practice.
Oncologist. 2003;8(5):411-24. doi: 10.1634/theoncologist.8-5-411.
10
Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats.
Eur J Neurosci. 2003 Jun;17(12):2648-58. doi: 10.1046/j.1460-9568.2003.02710.x.
Zotero 插件